SUSPECTED COUNTERFEIT PRODUCT

This adverse event was reported 3959 times

These drugs are most commonly taken by patients reporting SUSPECTED COUNTERFEIT PRODUCT:

# Drug Count
0 SILDENAFIL CITRATE 380
1 TADALAFIL 164
2 ORLISTAT 111
3 ALPRAZOLAM 101
4 BEVACIZUMAB 70
5 ORAL SEMAGLUTIDE 69
6 RIVAROXABAN 67
7 SILDENAFIL 61
8 ATORVASTATIN CALCIUM 53
9 OXYCODONE 52
See all common drugs associated with SUSPECTED COUNTERFEIT PRODUCT

SUSPECTED COUNTERFEIT PRODUCT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AVOBENZONE,HOMOSALATE,OCTINOXATE,OCTISALATE 1 1.0000
1 CHASTE TREE FRUIT 1 0.0417
2 BERACTANT 7 0.0190
3 ADEFOVIR DIPIVOXIL 19 0.0149
4 HUMAN RHO(D) IMMUNE GLOBULIN 14 0.0136
5 JOINT HEALTH CAPSULES 1 0.0133
6 IOBENGUANE I-123 1 0.0088
7 METHSCOPOLAMINE BROMIDE 1 0.0069
8 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 1 0.0055
9 TETRACAINE 2 0.0051
See all drugs enriched for association with SUSPECTED COUNTERFEIT PRODUCT

SUSPECTED COUNTERFEIT PRODUCT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Amino Acid Hypertonic Solution [EPC] 1 0.0063
1 Surfactant [EPC] 7 0.0060
2 Intestinal Lipase Inhibitor [EPC] 111 0.0047
3 Serotonin-4 Receptor Agonist [EPC] 2 0.0030
4 Opioid Antagonist [EPC] 2 0.0021
5 Human Immunoglobulin G [EPC] 41 0.0019
6 Phosphodiesterase 5 Inhibitor [EPC] 196 0.0014
7 Provitamin D2 Compound [EPC] 41 0.0014
8 Anthelmintic [EPC] 4 0.0014
9 Dopamine-2 Receptor Antagonist [EPC] 10 0.0013
See all drug classes enriched for association with SUSPECTED COUNTERFEIT PRODUCT